NCT07898618
Hypoglossal Nerve Stimulation in Obstructive Sleep Apnea With Complete Concentric Collapse
StatusNot Yet Recruiting
PhaseNot applicable
SponsorBrigham and Women's Hospital
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
HGNS-induced change in pharyngeal critical closing pressure (Pcrit)
Timeframe: During one overnight physiological study 4-12 months after implantation, once HGNS settings are stable
Secondary (12)
Percentage reduction in apnea-hypopnea index (AHI)
Percentage of participants meeting HGNS treatment-response criteria
HGNS use relative to total sleep time
Percentage of participants meeting HGNS adherence criteria
Epworth Sleepiness Scale
Show 7 moreShow less
PROMIS Sleep Disturbance Short Form 8b
PROMIS Sleep-Related Impairment Short Form 8a
Sleep Apnea Quality of Life Index - Short Form
PROMIS Fatigue Short Form 7a
Snoring severity visual analog scale
Treatment satisfaction visual analog scale
Number of participants with device-related adverse events or surgical complications
Arms and interventions
Investigational HGNS in CCCExperimental
Adults with complete concentric collapse receive Inspire HGNS implantation, activation, titration, and follow-up, with physiological testing and safety assessments through 12 months after implantation.
Devices: Inspire Hypoglossal Nerve Stimulation System
Sites
2 sites in 1 country